((2R,3S,5R)-5-(2,6-Dioxo-2,3-dihydro-1H-purin-9(6H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate

Catalog No. :
ACORUS805
CAS No. :
16541-23-4
Molecular Formula :
C10H15N4O14P3
Molecular Weight :
508.17

IUPAC Name:((2R,3S,5R)-5-(2,6-dioxo-1,2,3,6-tetrahydro-9H-purin-9-yl)-3-hydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate

((2R,3S,5R)-5-(2,6-Dioxo-2,3-dihydro-1H-purin-9(6H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name((2R,3S,5R)-5-(2,6-Dioxo-2,3-dihydro-1H-purin-9(6H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate
IUPAC Name((2R,3S,5R)-5-(2,6-dioxo-1,2,3,6-tetrahydro-9H-purin-9-yl)-3-hydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate
Molecular FormulaC10H15N4O14P3
Molecular Weight508.17
SMILESO=C1C2=C(N(C=N2)[C@@]3(O[C@H](COP(OP(OP(=O)(O)O)(=O)O)(=O)O)[C@@H](O)C3)[H])NC(=O)N1
InChI KeyWRTKMPONLHLBBL-KVQBGUIXSA-N
SynonymXanthosine 5'-(tetrahydrogen triphosphate), 2'-deoxy-;2'-Deoxyxanthosine 5'-triphosphate
CAS No.16541-23-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACORUS805 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACORUS805 route product structure diagram
    ACORUS80516541-23-4
Inquiry

2. ACORUS805 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACORUS805 route product structure diagram
    ACORUS80516541-23-4
Inquiry

Comments (0)